Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cullinan Therapeutics | CGEM | Jan 31, 2025 | 10.56 | -3.83 |
Culp | CULP | Jan 31, 2025 | 5.39 | +3.06 |
Cumberland Pharmaceuticals | CPIX | Jan 31, 2025 | 2.26 | +0.44 |
Cummins | CMI | Jan 31, 2025 | 356.25 | -0.95 |
Cumulus Media A | CMLS | Jan 31, 2025 | 0.91 | +4.60 |
Curbline Properties | CURB | Jan 31, 2025 | 24.47 | -1.13 |
Curevac N.V. | CVAC | Jan 31, 2025 | 3.79 | -0.79 |
CuriosityStream | CURI | Jan 31, 2025 | 2.59 | +18.81 |
Curis | CRIS | Jan 31, 2025 | 3.52 | +6.99 |
CURRENC Group | CURR | Jan 31, 2025 | 1.63 | +1.88 |
Curtiss-Wright | CW | Jan 31, 2025 | 346.94 | +0.03 |
Cushing Mlp & Infrastructure Total Return Fund | SRV | Jan 31, 2025 | 45.72 | -0.26 |
Cushman & Wakefield | CWK | Jan 31, 2025 | 13.79 | -0.58 |
Custom Truck One Source | CTOS | Jan 31, 2025 | 5.09 | -3.78 |
Customers Bancorp | CUBI | Jan 31, 2025 | 56.98 | -0.58 |
Customers Bancorp E Pref | CUBI-E | Jan 31, 2025 | 25.81 | -0.46 |
Customers Bancorp F Pref | CUBI-F | Jan 31, 2025 | 25.62 | +0.43 |
Cutera | CUTR | Jan 31, 2025 | 0.43 | +3.44 |
CVB Financial | CVBF | Jan 31, 2025 | 20.84 | -1.04 |
CVD Equipment | CVV | Jan 31, 2025 | 3.55 | +2.90 |
CVR Energy | CVI | Jan 31, 2025 | 18.95 | -0.63 |
Cvr Partners LP Unit | UAN | Jan 31, 2025 | 81.50 | -1.12 |
CVRx | CVRX | Jan 31, 2025 | 15.98 | -4.94 |
CVS Health | CVS | Jan 31, 2025 | 56.48 | -0.60 |
CXApp A | CXAI | Jan 31, 2025 | 1.51 | -1.31 |
CyberArk Software | CYBR | Jan 31, 2025 | 370.98 | -0.17 |
Cybin | CYBN | Jan 31, 2025 | 9.91 | -0.70 |
Cyclacel Pharmaceuticals | CYCC | Jan 31, 2025 | 0.33 | -7.09 |
Cyclacel Pharmaceuticals Pref | CYCCP | Jan 31, 2025 | 7.52 | +1.62 |
Cyclerion Therapeutics | CYCN | Jan 31, 2025 | 3.92 | +54.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.